B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 17
- +2 vs. Q2 2025
- Portfolio value
- $104.6M
- −$11.2M (−9.7%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ADMAAdma Biologics, Inc. | COM | 2,412,542 | $35.4M | 33.8% | +95,000+4.1% | Added | History |
| ZLABZai Lab Ltd | ADR | 400,000 | $13.6M | 13.0% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 232,446 | $11.0M | 10.6% | 00.0% | Unchanged | History |
| CLLSCellectis S.A. | SPON ADS | 3,281,501 | $9.35M | 8.9% | +25,000+0.8% | Added | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,800,556 | $5.89M | 5.6% | 00.0% | Unchanged | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 175,706 | $4.50M | 4.3% | −13,644−7.2% | Reduced | History |
| NRX Pharmaceuticals, Inc.629444118 | *W EXP 05/24/202 | 3,000,000 | $4.46M | 4.3% | +3,000,000 | New | – |
| RAREUltragenyx Pharmaceutical Inc. | COM | 135,000 | $4.06M | 3.9% | +25,000+22.7% | Added | History |
| AURAAura Biosciences, Inc. | COM | 572,576 | $3.54M | 3.4% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,500,000 | $3.25M | 3.1% | 00.0% | Unchanged | History |
| SGHTSight Sciences, Inc. | COM | 930,000 | $3.20M | 3.1% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 100,000 | $1.68M | 1.6% | +20,000+25.0% | Added | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 31,500 | $1.67M | 1.6% | −3,500−10.0% | Reduced | History |
| ORKAOruka Therapeutics, Inc. | COM | 75,000 | $1.44M | 1.4% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 35,000 | $1.39M | 1.3% | 00.0% | Unchanged | History |
| GAMEGameSquare Holdings, Inc. | COM | 250,000 | $169.7K | 0.2% | +250,000 | New | History |
| INSMINSMED Inc | COM PAR $.01 | 158 | $22.8K | <0.1% | −154,842−99.9% | Reduced | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.